Anthropic is launching its own drug development program for neglected diseases that the pharmaceutical industry considers unprofitable. Novartis CEO Vas Narasimhan thinks AI could cut development time [...]
Drug discovery is notoriously inefficient. Pharmaceutical projects span years, moving from one specialized human team to the next through disconnected workflows that result in knowledge loss during ea [...]
Earlier this summer Engadget covered the news that Warner Bros. Discovery would split into two giant media companies. Today the conglomerate announced the names for the restructured entities.<br /& [...]
Eli Lilly's digital chief admits that, so far, AI is paying off in pharma everywhere except where the industry hyped it most: drug discovery.<br /> The article AI is saving pharma billions [...]
A New York Times investigation has shed light on two billion-dollar deals that advanced in parallel under the Trump administration: a massive Emirati investment in a Trump-linked cryptocurrency ventur [...]
Paramount Skydance and Warner Bros. Discovery are officially merging. The studio paid Netflix the $2.8 billion termination fee it was owed for breaking its original deal to buy Warner Bros. earlier to [...]
Paramount Skydance CEO David Ellison is apparently still hopeful that investors will approve his $108.4 billion hostile takeover of Warner Bros. Discovery. Paramount Skydance announced Thursday that i [...]